News
July 9, 2008 – An article in the July issue of The Journal of Clinical Hypertension indicates an increased intake in ...
July 08, 2008
Technology
The Abiomed Inc. Impella 2.5 cardiac assist device was FDA cleared in 2008 for use for partial circulatory support for periods up to six hours. The intra-aortic balloon pump (IABP) also has 510(k) clearance and approximately 110,000 are used each year in the U.S.
July 08, 2008Technology
The FloTrac is reportedly the first minimally invasive hemodynamic monitoring device that connects to any existing arterial line and requires no manual calibration. The latest enhancement to the FloTrac software empowers clinicians with greater flexibility to trend and analyze the patient parameters in order to make better informed decisions, said the company.
July 08, 2008Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
July 9, 2008 – The Medical Imaging & Technology Alliance (MITA) today applauded the U.S. Congress for passing Medicare ...
July 08, 2008Technology
TRUMPF Medical Systems Inc. offers an in-light high definition (HD) operating room camera, the TruVidia HD, which captures and transmits razor sharp, true-to-life images. The camera offers a 1,080 line horizontal resolution and 2 million pixels. The images are said to be more than twice as clear as those available from standard definition cameras.
July 07, 2008News
July 8, 2008 - The University of Mississippi Medical Center and St. Peter’s Hospital each implemented a suite of IT ...
July 07, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
July 8, 2008 - Foothills Medical Centre, a leading medical centre for treating patients with cardiac rhythm abnormalities in Calgary, Alberta, has become the first facility in Canada to use the new Evolution Mechanical Dilator Sheath Set from Cook Medical for the removal of pacemaker leads, reportedly simplifying this potentially challenging medical procedure.
July 07, 2008News
July 8, 2008 - Expanding the application of endovascular aortic repair, Medtronic Inc. today announced two major ...
July 07, 2008News
July 7, 2008 - OrbusNeich today said data recently presented at the 17th Annual Meeting of the Japanese Society of ...
July 06, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
July 7, 2008 - InTouch Technologies Inc. today launched a new product feature, StrokeRESPOND, to extend the ...
July 06, 2008News
July 7, 2008 - The American Academy of Pediatrics (AAP) today issued new cholesterol screening and treatment ...
July 06, 2008News
July 3, 2008 - A multicenter trial with up to five years of follow-up continues to support the mid- and long-term durability and safety of the Zenith endovascular graft used for aneurysm repair.
July 02, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
July 3, 2008 - A unanimous federal jury in Texas recently found that two patents exclusively licensed to Pressure Products Medical Supplies Inc., which cover medical products called valved peel-away introducers used for placement and implantation of pacemaker leads, were valid and infringed by the FlowGuard and ViaSeal products marketed by Quan Emerteq Corp.
July 02, 2008
Technology
Boston Scientific Corp. offers the PROMUS Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The PROMUS Stent is a private-labeled XIENCE V Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific under an agreement executed prior to the 2006 acquisition of the former Guidant Corp. by Boston Scientific.
July 02, 2008News
July 1, 2008 - The impact of surgeons' annual aortic volume and other prognostic indicators have been revealed in early outcomes of ruptured abdominal aortic aneurysm (RAAA) repair in a recent study from the University of Pittsburgh Medical Center. Details of the study have been published in the July issue of the Journal of Vascular Surgery.
July 01, 2008